Biotech
> Clinical Ink appointed Jonathan Andrus as its chief data officer. Release
> BioConsortia brought on Andrew Jacobs as the head of its New Zealand R&D. Release
> Philip Gregory joined Bluebird Bio ($BLUE) as its CSO. Release
> Dara Erck joined Aeras as its vice president of external affairs. Release
> Tyme appointed Dr. Giuseppe Del Priore to be part of its medical advisory board. Release
> InVivo Therapeutics announced that Ann Merrifield would join as lead director. Release
> Twist Bioscience named Solange Glaize as its chief financial officer. Release
> ZS Pharma named Jeffrey Farrow as its CFO. Release
> OBN's Jon Rees stepped down from his position as CEO. Release
> ProNAi Therapeutics appointed Dr. Nicole Onetto and Robert Pelzer to its board of directors. Release
> SteadyMed ($STDY) added Elizabeth Cermak to its board of directors. Release
> Pulmatrix ($PULM) appointed Michael Higgins to its board of directors. Release
> AveXis named Sean Nolan as its CEO. Release
> Envisia Therapeutics appointed Eric Linsley as chief financial officer. Release
> City of Hope named Dr. John Zaia as director of its Center for Gene Therapy. Release
> Anavex added Steffen Thomas to its board of directors. Release
> Capricor Therapeutics ($CAPR) named Dr. Houman Hemmati as vice president of medical and clinical development for new therapies. Release
> Robert Hoffman, Arena Pharmaceuticals' ($ARNA) senior vice president of finance and CFO, will leave the company. Release
> Vigilant Biosciences added Dr. Linda Niessen to its board of directors. Release
> Tocagen named Dr. Asha Das as vice president of clinical development. Release
> Neogenomics ($NEO) elected Dr. Alison Hannah and Lynn Tetrault to its board of directors. Release
> Dr. Rajiv Shah joined Omeros' ($OMER) board of directors. Release
> Plasticell appointed Aaron T.T. Chuang as chief scientific officer. Release
> Agenus ($AGEN) named C. Evan Ballantyne as chief financial officer. Release
> Hemostemix appointed Rahul Sarugaser as vice president of business and corporate development. Release
Diagnostics
> Genetic Technologies appointed Brian Manuel as chief financial officer. Release
> Metastat elected Douglas Hamilton as president and CEO. Release
Vaccines
> Novavax ($NVAX) appointed Gail Boudreaux to its board of directors. Release
> VaxInnate added Dr. Thomas Monath to its board of directors. Release
|